Patricia Carr - Aug 15, 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
SVP, Chief Accounting Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Patricia Carr
Stock symbol
JAZZ
Transactions as of
Aug 15, 2022
Transactions value $
-$116,654
Form type
4
Date filed
8/17/2022, 04:41 PM
Previous filing
Aug 9, 2022
Next filing
Dec 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$22.3K -142 -2.34% $156.86 5.93K Aug 15, 2022 Direct F1
transaction JAZZ Ordinary Shares Options Exercise $226K +2K +33.7% $113.10 7.93K Aug 15, 2022 Direct
transaction JAZZ Ordinary Shares Sale -$321K -2K -25.21% $160.29 5.93K Aug 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -30.77% $0.00 4.5K Aug 15, 2022 Ordinary Shares 2K $113.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.